Analysts Set Quince Therapeutics, Inc. (NASDAQ:QNCX) Target Price at $9.50
Quince Therapeutics, Inc. (NASDAQ:QNCX – Get Free Report) has received a consensus rating of “Buy” from the six ratings firms that are currently covering the company, Marketbeat Ratings reports. Four analysts have rated the stock with a buy recommendation and two have given a strong buy recommendation to the company. The average 1 year target […]
Quince Therapeutics, Inc. (NASDAQ:QNCX – Get Free Report) has received a consensus rating of “Buy” from the six ratings firms that are currently covering the company, Marketbeat Ratings reports. Four analysts have rated the stock with a buy recommendation and two have given a strong buy recommendation to the company. The average 1 year target […]
